<div id="readability-page-1"><h3>Claim 50% Off TipRanks Premium</h3><ul><li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions </li><li> Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li></ul>NeOnc Technologies Holdings, Inc. ( (NTHI) ) has issued an announcement. On January 29, 2026, NeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to issue up to 2,222,222 shares of common stock at $7.20 per share and accompanying five-year warrants for an equal number of shares at an exercise price of $9.00. At the initial closing, the company sold 1,388,888 shares and warrants to a single institutional investor for $10 million, with additional closings expected, and plans to use the net proceeds to repay indebtedness and fund working capital. The securities were issued in a private placement exempt from Securities Act registration, and the company committed to file a resale registration statement for the shares and warrant shares within ten days of the initial closing, underscoring a strategy to strengthen its balance sheet and provide liquidity to the investor. The most recent analyst rating on (NTHI) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on NeOnc Technologies Holdings, Inc. stock, see the NTHI Stock Forecast page. Spark’s Take on NTHI Stock According to Spark, TipRanks’ AI Analyst, NTHI is a Neutral. The score is held back primarily by weak financial fundamentals (continued large losses, negative equity, and heavier cash burn). Offsetting this, technicals are moderately positive (price above key moving averages with positive MACD), and recent corporate updates are constructive (clinical data and partnership/financing announcements), while valuation remains constrained by ongoing unprofitability. To see Spark’s full report on NTHI stock, click here. More about NeOnc Technologies Holdings, Inc. NeOnc Technologies Holdings, Inc. operates in the biotechnology/pharmaceutical sector, focused on developing and commercializing medical technologies, with its capital-raising activities aimed at supporting its operations and financial obligations within this market. Average Trading Volume: 64,277 Technical Sentiment Signal: Hold Current Market Cap: $218.9M </div>

ARKG

NTHI

SBIO

NeOnc Technologies Holdings, Inc. announced a private placement equity financing deal on January 29, 2026, issuing up to 2,222,222 shares at $7.20 each, along with five-year warrants. The initial closing involved selling 1,388,888 shares for $10 million to an institutional investor. Proceeds will be used to repay debt and fund working capital. The company plans to file a resale registration statement within ten days. Analysts rate NTHI stock as a Hold with a $9.00 price target, citing weak financial fundamentals but moderately positive technicals.

NeOnc Technologies Announces Private Placement Equity Financing Deal